- The following list contains contact details for free formula programs in Canada for people living with HIV. If your region does not have a program specifically for people with HIV, there may be other…
- A review of best practices to improve awareness of and access to PrEP for women at risk of HIV infection and barriers and facilitators to PrEP uptake.
- CATIE NewsAn American study analysed blood and urine samples from women with and without HIV. Women with HIV were less likely to retain vitamin C in their bodies. The cause of the vitamin C loss was not clear…
- CATIE NewsAlthough the widespread availability of potent combination therapy for HIV infection (commonly called ART or HAART) greatly prolongs the survival of people, it ...
- Safety and effectiveness of long-acting cabotegravir for prevention in cisgender women
- This guide provides information about menopause for women living with HIV who are at any stage of their menopause transition.
- CATIE NewsResearchers enrolled 1,422 women living with HIV from British Columbia, Ontario and Quebec. Those who face stigma and discrimination were less likely to take medication as prescribed. The researchers…
- CATIE NewsCanadian study finds cervical cancer screening delayed in 30% of women with HIV. Pap tests are recommended on an annual basis for HIV-positive women in Canada. ...
- Dolutegravir belongs to a class of anti-HIV drugs called integrase inhibitors. In Canada and other high-income countries, dolutegravir is sold in the following ...
- CATIE NewsResearchers compared the health of HIV-positive and HIV-negative women. Women with HIV were nearly 60% more likely to have another health condition . ...